Your search returned 1590 results.

Results
	741.	Lapatinib: a sword with two edges. [electronic resource] by Kopper, László Producer: 20090326 In: Pathology oncology research : POR vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	742.	A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer. [electronic resource] by Whang, Young E Armstrong, Andrew J Rathmell, W Kimryn Godley, Paul A Kim, William Y Pruthi, Raj S Wallen, Eric M Crane, Jeffrey M Moore, Dominic T Grigson, Gayle Morris, Karla Watkins, Catharine P George, Daniel J Producer: 20130808 In: Urologic oncology vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	743.	Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization. [electronic resource] by Shan, Yibing Eastwood, Michael P Zhang, Xuewu Kim, Eric T Arkhipov, Anton Dror, Ron O Jumper, John Kuriyan, John Shaw, David E Producer: 20120702 In: Cell vol. 149 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	744.	HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib. [electronic resource] by Press, Michael F Ellis, Catherine E Gagnon, Robert C Grob, Tobias J Buyse, Marc Villalobos, Ivonne Liang, Zhiyong Wu, Shafei Bang, Yung-Jue Qin, Shu-Kui Chung, Hyun Cheol Xu, Jianming Park, Joon Oh Jeziorski, Krzysztof Afenjar, Karen Ma, Yanling Estrada, Monica C Robinson, Douglas M Scherer, Stefan J Sauter, Guido Hecht, J Randolph Slamon, Dennis J Producer: 20170629 In: Molecular cancer therapeutics vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	745.	Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer Compound. [electronic resource] by Lin, Chun-Han Jokela, Tiina Gray, Joe LaBarge, Mark A Producer: 20180613 In: Cell reports vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	746.	Cabazitaxel Plus Lapatinib as Therapy for HER2 [electronic resource] by Yardley, Denise A Hart, Lowell L Ward, Patrick J Wright, Gail L Shastry, Mythili Finney, Lindsey DeBusk, Laura M Hainsworth, John D Producer: 20190919 In: Clinical breast cancer vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	747.	Heat shock factor 1 confers resistance to lapatinib in ERBB2-positive breast cancer cells. [electronic resource] by Yallowitz, Alisha Ghaleb, Amr Garcia, Lucas Alexandrova, Evguenia M Marchenko, Natalia Producer: 20191210 In: Cell death & disease vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	748.	Phosphoproteomic analysis reveals PAK2 as a therapeutic target for lapatinib resistance in HER2-positive breast cancer cells. [electronic resource] by Chang, Yoojin Park, Kyong Hwa Lee, Ji Eun Han, Ki-Cheol Producer: 20190528 In: Biochemical and biophysical research communications vol. 505 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	749.	Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer: Long-term Results of Treatment With Trastuzumab and Lapatinib. [electronic resource] by Sartore-Bianchi, Andrea Lonardi, Sara Aglietta, Massimo Martino, Cosimo Ciardiello, Fortunato Marsoni, Silvia Siena, Salvatore Producer: 20210122 In: JAMA oncology vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	750.	Lapatinib in combination with radiation diminishes tumor regrowth in HER2+ and basal-like/EGFR+ breast tumor xenografts. [electronic resource] by Sambade, Maria J Kimple, Randall J Camp, J Terese Peters, Eldon Livasy, Chad A Sartor, Carolyn I Shields, Janiel M Producer: 20100524 In: International journal of radiation oncology, biology, physics vol. 77 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	751.	Trastuzumab in gastric cancer. [electronic resource] by Okines, Alicia F C Cunningham, David Producer: 20101129 In: European journal of cancer (Oxford, England : 1990) vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	752.	Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors. [electronic resource] by Simonelli, Matteo Zucali, Paolo A Lorenzi, Elena Rubino, Luca De Vincenzo, Fabio De Sanctis, Rita Perrino, Matteo Mancini, Luca Di Tommaso, Luca Rimassa, Lorenza Masci, Giovanna Zuradelli, Monica Suter, Matteo B Bertossi, Monica Fattuzzo, Giuseppe Giordano, Laura Roncalli, Massimo G Santoro, Armando Producer: 20130424 In: European journal of cancer (Oxford, England : 1990) vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	753.	The effects of anti-VEGFR and anti-EGFR agents on glioma cell migration through implication of growth factors with integrins. [electronic resource] by Dimitropoulos, Konstantinos Giannopoulou, Efstathia Argyriou, Andreas A Zolota, Vassiliki Petsas, Theodore Tsiata, Ekaterini Kalofonos, Haralabos P Producer: 20110204 In: Anticancer research vol. 30 Availability: No items available. Save to lists Add to cart (remove)
	754.	Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy. [electronic resource] by Zhang, Zichen Oyesanya, Regina A Campbell, Deanna J W Almenara, Jorge A Dewitt, Jennifer L Sirica, Alphonse E Producer: 20101007 In: Hepatology (Baltimore, Md.) vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	755.	Ki-67 index as a prognostic factor of subsequent lapatinib-based therapy in HER2-positive metastatic breast cancer with resistance to trastuzumab. [electronic resource] by Bian, Li Wang, Tao Zhang, Shao-Hua Zhang, Hui-Qiang Guo, Yun-Fei Du, Ge Li, Wang Wu, Shi-Kai Song, San-Tai Jiang, Ze-Fei Producer: 20150420 In: Cancer biology & therapy vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	756.	Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine. [electronic resource] by Geva, Shahar Lazarev, Irena Geffen, David Barry Ariad, Samuel Producer: 20131028 In: Journal of chemotherapy (Florence, Italy) vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	757.	Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer. [electronic resource] by Holdman, Xue B Welte, Thomas Rajapakshe, Kimal Pond, Adam Coarfa, Cristian Mo, Qianxing Huang, Shixia Hilsenbeck, Susan G Edwards, Dean P Zhang, Xiang Rosen, Jeffrey M Producer: 20160421 In: Breast cancer research : BCR vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	758.	Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2): positive advanced breast cancer. [electronic resource] by Le, Quang A Bae, Yuna H Kang, Jenny H Producer: 20171213 In: Breast cancer research and treatment vol. 159 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	759.	Feedback activation of HER3 attenuates response to EGFR inhibitors in colon cancer cells. [electronic resource] by Bosch-Vilaró, Albert Jacobs, Bart Pomella, Valentina Abbasi Asbagh, Layka Kirkland, Richard Michel, Joe Singh, Sharat Liu, Xinjun Kim, Phillip Weitsman, Gregory Barber, Paul R Vojnovic, Borivoj Ng, Tony Tejpar, Sabine Producer: 20180223 In: Oncotarget vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	760.	Real-world data of lapatinib and treatment after lapatinib in patients with previously treated HER2-positive metastatic breast cancer: A multicenter, retrospective study. [electronic resource] by Xie, Yizhao Ge, Rui Sang, Die Luo, Ting Li, Wei Ji, Xuening Yuan, Peng Wang, Biyun Producer: 20210514 In: Cancer medicine vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1590 results.